Michael John Wilkins

Title: Michael John Wilkins: Innovator in Nanoparticulate Fibrate Formulations

Introduction

Michael John Wilkins is a notable inventor based in Midleton, Ireland. He has made significant contributions to the field of pharmacology, particularly in the development of nanoparticulate fibrate formulations. With a total of 4 patents to his name, Wilkins has demonstrated a commitment to advancing medical science through innovative solutions.

Latest Patents

Among his latest patents, Wilkins has focused on nanoparticulate fibrate formulations. These inventions are directed towards fibrate compositions that exhibit improved pharmacokinetic profiles and reduced fed/fasted variability. The fibrate particles in these compositions have an effective average particle size of less than about 2000 nm, which enhances their efficacy and reliability in medical applications.

Career Highlights

Throughout his career, Wilkins has worked with prominent companies in the pharmaceutical industry, including Elan Pharma International Limited and Fournier Laboratories Ireland Limited. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development in drug formulation.

Collaborations

Wilkins has collaborated with several professionals in his field, including Tuula Ryde and Evan E Gustow. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Michael John Wilkins stands out as a significant figure in the realm of nanoparticulate formulations, with a focus on improving drug delivery systems. His contributions continue to impact the pharmaceutical industry positively.